<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38304426</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome.</ArticleTitle><Pagination><StartPage>1341843</StartPage><MedlinePgn>1341843</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1341843</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1341843</ELocationID><Abstract><AbstractText Label="INTRODUCTION">A group of SARS-CoV-2 infected individuals present lingering symptoms, defined as long COVID (LC), that may last months or years post the onset of acute disease. A portion of LC patients have symptoms similar to myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), which results in a substantial reduction in their quality of life. A better understanding of the pathophysiology of LC, in particular, ME/CFS is urgently needed.</AbstractText><AbstractText Label="METHODS">We identified and studied metabolites and soluble biomarkers in plasma from LC individuals mainly exhibiting ME/CFS compared to age-sex-matched recovered individuals (R) without LC, acute COVID-19 patients (A), and to SARS-CoV-2 unexposed healthy individuals (HC).</AbstractText><AbstractText Label="RESULTS">Through these analyses, we identified alterations in several metabolomic pathways in LC vs other groups. Plasma metabolomics analysis showed that LC differed from the R and HC groups. Of note, the R group also exhibited a different metabolomic profile than HC. Moreover, we observed a significant elevation in the plasma pro-inflammatory biomarkers (e.g. IL-1&#x3b1;, IL-6, TNF-&#x3b1;, Flt-1, and sCD14) but the reduction in ATP in LC patients. Our results demonstrate that LC patients exhibit persistent metabolomic abnormalities 12 months after the acute COVID-19 disease. Of note, such metabolomic alterations can be observed in the R group 12 months after the acute disease. Hence, the metabolomic recovery period for infected individuals with SARS-CoV-2 might be long-lasting. In particular, we found a significant reduction in sarcosine and serine concentrations in LC patients, which was inversely correlated with depression, anxiety, and cognitive dysfunction scores.</AbstractText><AbstractText Label="CONCLUSION">Our study findings provide a comprehensive metabolomic knowledge base and other soluble biomarkers for a better understanding of the pathophysiology of LC and suggests sarcosine and serine supplementations might have potential therapeutic implications in LC patients. Finally, our study reveals that LC disproportionally affects females more than males, as evidenced by nearly 70% of our LC patients being female.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Saito, Shahbaz, Luo, Osman, Redmond, Cohen Tervaert, Li and Elahi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Suguru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahbaz</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Centre, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redmond</LastName><ForeName>Desiree</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen Tervaert</LastName><ForeName>Jan Willem</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Centre, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elahi</LastName><ForeName>Shokrollah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Virology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>Z711V88R5F</RegistryNumber><NameOfSubstance UI="D012521">Sarcosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012521" MajorTopicYN="N">Sarcosine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognitive performance</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">sarcosine</Keyword><Keyword MajorTopicYN="N">serine</Keyword><Keyword MajorTopicYN="N">soluble CD14</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>2</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38304426</ArticleId><ArticleId IdType="pmc">PMC10830702</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1341843</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci CMLS. (2022) 79(3):187. doi: 10.1007/s00018-022-04220-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04220-6</ArticleId><ArticleId IdType="pmc">PMC8918078</ArticleId><ArticleId IdType="pubmed">35284964</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol (2022) 322(1):C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PloS Med (2021) 18(9):e1003773. doi: 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, O'Hara M, Evans S, Agyen L, et al. . Long COVID guidelines need to reflect lived experience. Lancet (2021) 397(10273):455&#x2013;7. doi: 10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol (2022) 23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakamutumaho B, Cummings MJ, Owor N, Kayiwa J, Namulondo J, Byaruhanga T, et al. . Severe COVID-19 in Uganda across two epidemic phases: A prospective cohort study. Am J Trop Med Hyg (2021) 105(3):740&#x2013;4. doi: 10.4269/ajtmh.21-0551</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-0551</ArticleId><ArticleId IdType="pmc">PMC8592357</ArticleId><ArticleId IdType="pubmed">34370701</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The long haul. Science (2020) 369(6504):614&#x2013;7. doi: 10.1126/science.369.6504.614</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.369.6504.614</ArticleId><ArticleId IdType="pubmed">32764050</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums DV. Editorial: long COVID, or post-COVID syndrome, and the global impact on health care. Med Sci Monitor (2021) 27:e933446. doi: 10.12659/MSM.933446</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933446</ArticleId><ArticleId IdType="pmc">PMC8194290</ArticleId><ArticleId IdType="pubmed">34092779</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota HR, Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol (2022) 41(2):337&#x2013;48. doi: 10.1007/s10067-021-06001-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. Jama (2020) 324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-haul COVID. Neurology (2020) 95(13):559&#x2013;60. doi: 10.1212/WNL.0000000000010640</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Russell AS. A questionnaire using the modified 2010 american college of rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice. J Rheumatol (2013) 40(9):1590&#x2013;5. doi: 10.3899/jrheum.130367</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.130367</ArticleId><ArticleId IdType="pubmed">23818707</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med (2021) 27(9):895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav (2020) 14(2):562&#x2013;72. doi: 10.1007/s11682-018-0029-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-0029-4</ArticleId><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang CY, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature (2022) 604(7907):697&#x2013;+. doi: 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan RG, Zhang QR, Anthony SM, Zhou Y, Zou XF, Cassell M, et al. . Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proc Natl Acad Sci United States America. (2020) 117(27):15902&#x2013;10. doi: 10.1073/pnas.2003432117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003432117</ArticleId><ArticleId IdType="pmc">PMC7355048</ArticleId><ArticleId IdType="pubmed">32571951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Do vaccines protect against long COVID? What the data say. Nature (2021) 559(7886):546&#x2013;8. doi: 10.1038/d41586-021-03495-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03495-2</ArticleId><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci (2021) 24(2):168&#x2013;75. doi: 10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels BP, Holman DW, Cruz-Orengo L, Jujjavarapu H, Durrant DM, Klein RS. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. mBio (2014) 5(5):e01476&#x2013;14. doi: 10.1128/mBio.01476-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01476-14</ArticleId><ArticleId IdType="pmc">PMC4173776</ArticleId><ArticleId IdType="pubmed">25161189</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiat. (2021) 78(6):682&#x2013;3. doi: 10.1001/jamapsychiatry.2021.0500</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med (2021) 27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosef C, Knauer MJ, Nicholson M, Van Nynatten LR, Cepinskas G, Draghici S, et al. . Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function. J Trans Med (2023) 21(1):377. doi: 10.1186/s12967-023-04149-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04149-9</ArticleId><ArticleId IdType="pmc">PMC10257382</ArticleId><ArticleId IdType="pubmed">37301958</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol (2021) 21(4):245&#x2013;56. doi: 10.1038/s41577-021-00522-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci Biobehav Rev (2015) 57:30&#x2013;45. doi: 10.1016/j.neubiorev.2015.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2015.07.015</ArticleId><ArticleId IdType="pubmed">26363665</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of fatigue. Trends Neurosci (2014) 37(1):39&#x2013;46. doi: 10.1016/j.tins.2013.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2013.10.003</ArticleId><ArticleId IdType="pmc">PMC3889707</ArticleId><ArticleId IdType="pubmed">24239063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med (2005) 39(5):584&#x2013;9. doi: 10.1016/j.freeradbiomed.2005.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.04.020</ArticleId><ArticleId IdType="pubmed">16085177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest (2020) 130(3):1491&#x2013;505. doi: 10.1172/JCI132185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci United States America. (2016) 113(37):E5472&#x2013;80. doi: 10.1073/pnas.1607571113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen RCW, Kurk RM, Visser FC, Sluiter W, Scholte HR. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J Trans Med (2010) 8:93. doi:&#xa0;10.1186/1479-5876-8-93</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-8-93</ArticleId><ArticleId IdType="pmc">PMC2964609</ArticleId><ArticleId IdType="pubmed">20937116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Sunnquist M, Brown A, Evans M, Vernon SD, Furst J, et al. . Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis. Fatigue (2014) 2(1):40&#x2013;56. doi:&#xa0;10.1080/21641846.2013.862993</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2013.862993</ArticleId><ArticleId IdType="pmc">PMC3912876</ArticleId><ArticleId IdType="pubmed">24511456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Trans Med (2020) 18(1):100. doi:&#xa0;10.1186/s12967-020-02269-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedree H, Sunnquist M, Jason LA. The dePaul symptom questionnaire-2: A validation study. Fatigue (2019) 7(3):166&#x2013;79. doi:&#xa0;10.1080/21641846.2019.1653471</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2019.1653471</ArticleId><ArticleId IdType="pmc">PMC7367506</ArticleId><ArticleId IdType="pubmed">32685281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandasegui IM, Laka LA, Gargiulo PA, Gomez-Esteban JC, Sanchez JVL. Myalgic encephalomyelitis/chronic fatigue syndrome: A neurological entity? Medicina-Lithuania (2021) 57(10):1030. doi:&#xa0;10.3390/medicina57101030</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57101030</ArticleId><ArticleId IdType="pmc">PMC8540700</ArticleId><ArticleId IdType="pubmed">34684066</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk FNM. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&amp;NS) pathways may explain cardiovascular disorders in ME/CFS. Neuroendocrinol Lett (2009) 30(6):677&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">20038921</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, Slessarev M, Martin CM, Daley M, Patel MA, Miller MR, et al. . Metabolomics profiling of critically ill coronavirus disease 2019 patients: identification of diagnostic and prognostic biomarkers. Crit Care Explor (2020) 2(10):e0272. doi: 10.1097/CCE.0000000000000272</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000272</ArticleId><ArticleId IdType="pmc">PMC7587450</ArticleId><ArticleId IdType="pubmed">33134953</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Dunsmore G, Koleva P, Elloumi Y, Wu RY, Sutton RT, et al. . The profile of human milk metabolome, cytokines, and antibodies in inflammatory bowel diseases versus healthy mothers, and potential impact on the newborn. J Crohns Colitis. (2019) 13(4):431&#x2013;41. doi: 10.1093/ecco-jcc/jjy186</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjy186</ArticleId><ArticleId IdType="pmc">PMC6441305</ArticleId><ArticleId IdType="pubmed">30418545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang ZQ, Chong J, Zhou GY, Morais DAD, Chang L, Barrette M, et al. . MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res (2021) 49(W1):W388&#x2013;W96. doi:&#xa0;10.1093/nar/gkab382</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab382</ArticleId><ArticleId IdType="pmc">PMC8265181</ArticleId><ArticleId IdType="pubmed">34019663</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Zhou M, Luo P, Yin Z, Wang S, Liao T, et al. . Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 months after discharge. Clin Infect Dis (2021) 73(12):2228&#x2013;39. doi: 10.1093/cid/ciab147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab147</ArticleId><ArticleId IdType="pmc">PMC7929060</ArticleId><ArticleId IdType="pubmed">33596592</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkattawy S, Alyacoub R, Ayad S, Pandya M, Eckman A. A novel case of hypoparathyroidism secondary to SARS-coV-2 infection. Cureus (2020) 12(8):e10097. doi: 10.7759/cureus.10097</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10097</ArticleId><ArticleId IdType="pmc">PMC7522187</ArticleId><ArticleId IdType="pubmed">33005518</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Han P, Wu J, Gong J, Tian D. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients. J Infect Public Health (2020) 13(9):1224&#x2013;8. doi: 10.1016/j.jiph.2020.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.05.029</ArticleId><ArticleId IdType="pmc">PMC7306733</ArticleId><ArticleId IdType="pubmed">32622796</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva GB, Manica D, da Silva AP, Kosvoski GC, Hanauer M, Assmann CE, et al. . High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity. J Mol Med (Berl). (2022) 100(4):645&#x2013;63. doi: 10.1007/s00109-022-02185-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-022-02185-4</ArticleId><ArticleId IdType="pmc">PMC8898096</ArticleId><ArticleId IdType="pubmed">35249135</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. . Proteomic and metabolomic characterization of COVID-19 patient sera. Cell (2020) 182(1):59&#x2013;72 e15. doi:&#xa0;10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. . COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight (2020) 5(14):e140327. doi: 10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Sheedy JR, Buttfield I, Butt HL, Gooley PR. NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome. Clin Chim Acta (2012) 413(19-20):1525&#x2013;31. doi: 10.1016/j.cca.2012.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2012.06.022</ArticleId><ArticleId IdType="pubmed">22728138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G, Barcza M, Gonchoroff N, Phillips PE, Perl A. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol (2004) 173(6):3676&#x2013;83. doi: 10.4049/jimmunol.173.6.3676</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.6.3676</ArticleId><ArticleId IdType="pmc">PMC4034140</ArticleId><ArticleId IdType="pubmed">15356113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K, Furuya S, Osuka S, Mitoma J, Shinoda Y, Watanabe M, et al. . Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality. J Biol Chem (2004) 279(5):3573&#x2013;7. doi: 10.1074/jbc.C300507200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C300507200</ArticleId><ArticleId IdType="pubmed">14645240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaie L, Klomp LW, Rubio-Gozalbo ME, Spaapen LJ, Haagen AA, Dorland L, et al. . Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency. J Inherit Metab Dis (2011) 34(1):181&#x2013;4. doi: 10.1007/s10545-010-9249-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-010-9249-5</ArticleId><ArticleId IdType="pmc">PMC3026672</ArticleId><ArticleId IdType="pubmed">21113737</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtas G, Marcone GL, Sacchi S, Pollegioni L. L-serine synthesis via the phosphorylated pathway in humans. Cell Mol Life Sci CMLS. (2020) 77(24):5131&#x2013;48. doi: 10.1007/s00018-020-03574-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03574-z</ArticleId><ArticleId IdType="pmc">PMC11105101</ArticleId><ArticleId IdType="pubmed">32594192</ArticleId></ArticleIdList></Reference><Reference><Citation>de Koning TJ. Amino acid synthesis deficiencies. J Inherit Metab Dis (2017) 40(4):609&#x2013;20. doi: 10.1007/s10545-017-0063-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-017-0063-1</ArticleId><ArticleId IdType="pmc">PMC5500668</ArticleId><ArticleId IdType="pubmed">28653176</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKay MB, Kravtsenyuk M, Thomas R, Mitchell ND, Dursun SM. Baker GB. D-Serine: Potential Ther Agent and/or biomark Schizophr Depression? Front Psychiatry (2019) 10:25. doi:&#xa0;10.3389/fpsyt.2019.00025</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6372501</ArticleId><ArticleId IdType="pubmed">30787885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Wei IH, Huang CL, Chen KT, Tsai MH, Tsai P, et al. . Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biol Psychiat. (2013) 74(10):734&#x2013;41. doi: 10.1016/j.biopsych.2013.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2013.02.020</ArticleId><ArticleId IdType="pubmed">23562005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Ahmad MA, Najmi AK, Akhtar M. Effect of sarcosine (a glycine transport 1 inhibitor) and risperidone (an atypical antipsychotic drug) on MK-801 induced learning and memory deficits in rats. Drug Res (Stuttg). (2016) 66(1):11&#x2013;7. doi:&#xa0;10.1055/s-0035-1545299</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1545299</ArticleId><ArticleId IdType="pubmed">25710578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CH, Huang HC, Liu BL, Li CI, Lu MK, Chen X, et al. . Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia. Psychiatry Clin Neurosci (2014) 68(9):692&#x2013;700. doi: 10.1111/pcn.12175</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12175</ArticleId><ArticleId IdType="pubmed">24612097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KT, Wu CH, Tsai MH, Wu YC, Jou MJ, Huang CC, et al. . Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress. Behav Brain Res (2017) 316:1&#x2013;10. doi: 10.1016/j.bbr.2016.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2016.06.004</ArticleId><ArticleId IdType="pubmed">27555541</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters RO, Arias E, Diaz A, Burgos ES, Guan FX, Tiano S, et al. . Sarcosine is uniquely modulated by aging and dietary restriction in rodents and humans. Cell Rep (2018) 25(3):663&#x2013;+. doi: 10.1016/j.celrep.2018.09.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.09.065</ArticleId><ArticleId IdType="pmc">PMC6280974</ArticleId><ArticleId IdType="pubmed">30332646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindseth G, Helland B, Caspers J. The effects of dietary tryptophan on affective disorders. Arch Psychiat Nurs. (2015) 29(2):102&#x2013;7. doi: 10.1016/j.apnu.2014.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apnu.2014.11.008</ArticleId><ArticleId IdType="pmc">PMC4393508</ArticleId><ArticleId IdType="pubmed">25858202</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F, LesouHaitier M, Gregoire M, Pinceaux K, Gacouin A, Maamar A, et al. . SARS-coV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage. J Clin Immunol (2021) 41(3):515&#x2013;25. doi: 10.1007/s10875-020-00920-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Xu L, Osman M, Sligl W, Shields J, Joyce M, et al. . Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Rep (2021) 16(5):1165&#x2013;81. doi: 10.1016/j.stemcr.2021.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8111797</ArticleId><ArticleId IdType="pubmed">33979601</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Shahbaz S, Sligl W, Osman M, Tyrrell DL, Elahi S. Differential impact of SARS-coV-2 isolates, namely, the wuhan strain, delta, and omicron variants on erythropoiesis. Microbiol Spectr 2022. 10(4):e0173022. doi: 10.1128/spectrum.01730-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01730-22</ArticleId><ArticleId IdType="pmc">PMC9430111</ArticleId><ArticleId IdType="pubmed">35943266</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, et al. . Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results first interim analysis. Eclinicalmedicine. (2021) 40:101125. doi: 10.1016/j.eclinm.2021.101125</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Errico F, Nuzzo T, Carella M, Bertolino A, Usiello A. The emerging role of altered d-aspartate metabolism in schizophrenia: new insights from preclinical models and human studies. Front Psychiatry (2018) 9:559. doi: 10.3389/fpsyt.2018.00559</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00559</ArticleId><ArticleId IdType="pmc">PMC6232865</ArticleId><ArticleId IdType="pubmed">30459655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi S, Novellis V, Paolone G, Nuzzo T, Iannotta M, Belardo C, et al. . Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. Sci Rep (2017) 7:46288. doi: 10.1038/srep46288</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46288</ArticleId><ArticleId IdType="pmc">PMC5385520</ArticleId><ArticleId IdType="pubmed">28393897</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher M, Brunner F, Faulhaber M, Hotter B, Likar R. The prolonged intake of L-arginine-L-aspartate reduces blood lactate accumulation and oxygen consumption during submaximal exercise. J Sports Sci Med (2005) 4(3):314&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3887335</ArticleId><ArticleId IdType="pubmed">24453536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Ying Z, Bosy-Westphal A, Zhang J, Schautz B, Later W, et al. . Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am J Clin Nutr (2010) 92(6):1369&#x2013;77. doi: 10.3945/ajcn.2010.29885</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2010.29885</ArticleId><ArticleId IdType="pmc">PMC2980962</ArticleId><ArticleId IdType="pubmed">20962155</ArticleId></ArticleIdList></Reference><Reference><Citation>Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. . Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 360(9328):219&#x2013;23. doi: 10.1016/S0140-6736(02)09459-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09459-X</ArticleId><ArticleId IdType="pubmed">12133657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, Huttemann M. Energy crisis: the role of oxidative phosphorylation in acute inflammation and sepsis. Biochim Biophys Acta (2014) 1842(9):1579&#x2013;86. doi: 10.1016/j.bbadis.2014.05.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.05.031</ArticleId><ArticleId IdType="pmc">PMC4147665</ArticleId><ArticleId IdType="pubmed">24905734</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S, Booth NE, McLaren-Howard J. Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit. Int J Clin Exp Med (2013) 6(1):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515971</ArticleId><ArticleId IdType="pubmed">23236553</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Cordero MD, Saez-Francas N, Jimenez-Gutierrez C, Aguilar-Montilla FJ, Aliste L, et al. . Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Sign (2013) 19(15):1855&#x2013;60. doi: 10.1089/ars.2013.5346</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5346</ArticleId><ArticleId IdType="pubmed">23600892</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano M, Imamura H, Sasaoka N, Yamamoto M, Uemura N, Shudo T, et al. . ATP maintenance via two types of ATP regulators mitigates pathological phenotypes in mouse models of parkinson's disease. Ebiomedicine (2017) 22:225&#x2013;41. doi: 10.1016/j.ebiom.2017.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.07.024</ArticleId><ArticleId IdType="pmc">PMC5552266</ArticleId><ArticleId IdType="pubmed">28780078</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Z, Lu J. Involvement of aryl hydrocarbon receptor in L-kynurenine-mediated parathyroid hormone-related peptide expression. Horm Cancer (2019) 10(2-3):89&#x2013;96. doi: 10.1007/s12672-019-0357-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12672-019-0357-x</ArticleId><ArticleId IdType="pmc">PMC10355699</ArticleId><ArticleId IdType="pubmed">30689168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha S, Jin B, Clemmensen B, Park P, Mahboob S, Gladwill V, et al. . Serotonin is elevated in COVID-19-associated diarrhoea. Gut (2021) 70(10):2015&#x2013;+. doi: 10.1136/gutjnl-2020-323542</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323542</ArticleId><ArticleId IdType="pmc">PMC9208360</ArticleId><ArticleId IdType="pubmed">33402416</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca W, Malinczak CA, Schuler CF, Best SKK, Rasky AJ, Morris SB, et al. . Uric acid pathway activation during respiratory virus infection promotes Th2 immune response via innate cytokine production and ILC2 accumulation. Mucosal Immunol (2020) 13(4):691&#x2013;701. doi: 10.1038/s41385-020-0264-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-0264-z</ArticleId><ArticleId IdType="pmc">PMC7316593</ArticleId><ArticleId IdType="pubmed">32047272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, et al. . A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience (2023) 26(1):105717. doi: 10.1016/j.isci.2022.105717</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Omori K, Katakami N, Yamamoto Y, Ninomiya H, Takahara M, Matsuoka TA, et al. . Identification of metabolites associated with onset of CAD in diabetic patients using CE-MS analysis: A pilot study. J Atheroscler Thromb (2019) 26(3):233&#x2013;45. doi: 10.5551/jat.42945</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.42945</ArticleId><ArticleId IdType="pmc">PMC6402886</ArticleId><ArticleId IdType="pubmed">30068816</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva R, de Sarges KML, Cantanhede MHD, da Costa FP, Dos Santos EF, Rodrigues FBB, et al. . Thrombophilia and immune-related genetic markers in long COVID. Viruses (2023) 15(4):885. doi: 10.3390/v15040885</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040885</ArticleId><ArticleId IdType="pmc">PMC10143911</ArticleId><ArticleId IdType="pubmed">37112866</ArticleId></ArticleIdList></Reference><Reference><Citation>Labarrere CA, Kassab GS. Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation. Front Nutr (2022) 9. doi: 10.3389/fnut.2022.1007816</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.1007816</ArticleId><ArticleId IdType="pmc">PMC9664149</ArticleId><ArticleId IdType="pubmed">36386929</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodriguez Y, Acosta-Ampudia Y, Monsalve DM, Zhu CS, Li QZ, et al. . Autoimmun is hallmark post-COVID syndrome. J Trans Med (2022) 20(1):129. doi: 10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell (2022) 185(5):881&#x2013;95 e20. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Khoramjoo M, Srinivasan K, Gordon PMK, Mandal R, Jackson D, et al. . Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID. Cell Rep Med (2023) 4(11):101254. doi: 10.1016/j.xcrm.2023.101254</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2023.101254</ArticleId><ArticleId IdType="pmc">PMC10694626</ArticleId><ArticleId IdType="pubmed">37890487</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Bozorgmehr N, Lu J, Osman M, Sligl W, Tyrrell DL, et al. . Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles. Microbiol Spectr. (2023) 11(5):e0125623. doi: 10.1128/spectrum.01256-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01256-23</ArticleId><ArticleId IdType="pmc">PMC10581158</ArticleId><ArticleId IdType="pubmed">37676005</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo K, Li L. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem (2009) 81(10):3919&#x2013;32. doi: 10.1021/ac900166a</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac900166a</ArticleId><ArticleId IdType="pubmed">19309105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Mashhouri S, Perez Rosero E, Xu L, Shahbaz S, Sligl W, et al. . Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-coV-2 infection. mBio (2021) 12(3):e00384-21. doi: 10.1128/mBio.00384-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00384-21</ArticleId><ArticleId IdType="pmc">PMC8262904</ArticleId><ArticleId IdType="pubmed">33947753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Okoye I, Oyegbami O, Xu L, Fontaine A, Cox-Kennett N, et al. . Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia. J Immunother Cancer (2021) 9(4):e002189. doi: 10.1136/jitc-2020-002189</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-002189</ArticleId><ArticleId IdType="pmc">PMC8098955</ArticleId><ArticleId IdType="pubmed">33931471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Syed H, Mashhouri S, Walker J, Elahi S. Transcriptomic profiling of peripheral blood cells in HPV-associated carcinoma patients receiving combined valproic acid and avelumab. Mol Oncol (2023). doi: 10.1002/1878-0261.13519</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1878-0261.13519</ArticleId><ArticleId IdType="pmc">PMC11077001</ArticleId><ArticleId IdType="pubmed">37681284</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Okoye I, Blevins G, Elahi S. Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals. PloS Pathog (2022) 18(3):e1010378. doi: 10.1371/journal.ppat.1010378</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010378</ArticleId><ArticleId IdType="pmc">PMC8947394</ArticleId><ArticleId IdType="pubmed">35325005</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>